Drug information for RABEPRAZOLE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
TABLET, DELAYED RELEASE; ORAL 20MG Tentative Approval   RABEPRAZOLE SODIUM rabeprazole MYLAN PHARMA 76885
2006-01-20 Letter

Drug Adverse Effects information for RABEPRAZOLE

Role code Indications Reaction # Reports
C ANGINA PECTORIS INTERSTITIAL LUNG DISEASE 3
C ANGINA PECTORIS RENAL IMPAIRMENT 3
C ARTHRITIS CATARACT OPERATION 1
C BLOOD CHOLESTEROL CATARACT 2
C BLOOD CHOLESTEROL LASER THERAPY 2
C BLOOD CHOLESTEROL VISUAL ACUITY REDUCED 2
C BLOOD PRESSURE CATARACT 2
C BLOOD PRESSURE LASER THERAPY 2
C BLOOD PRESSURE VISUAL ACUITY REDUCED 2
C BRAIN OEDEMA INTERSTITIAL LUNG DISEASE 1
C BRAIN OEDEMA RENAL IMPAIRMENT 1
C DIABETES MELLITUS CATARACT 2
C DIABETES MELLITUS INTERSTITIAL LUNG DISEASE 2
C DIABETES MELLITUS LASER THERAPY 2
C DIABETES MELLITUS RENAL IMPAIRMENT 2
C DIABETES MELLITUS VISUAL ACUITY REDUCED 2
C DYSPEPSIA CATARACT 2
C DYSPEPSIA LASER THERAPY 2
C DYSPEPSIA VISUAL ACUITY REDUCED 2
C GASTRIC ULCER INTERSTITIAL LUNG DISEASE 2
C GASTRIC ULCER RENAL IMPAIRMENT 2
C GASTROOESOPHAGEAL REFLUX DISEASE CATARACT OPERATION 1
C GLAUCOMA CATARACT 3
C GLAUCOMA CATARACT OPERATION 1
C GLAUCOMA INTRAOCULAR PRESSURE INCREASED 2
C GLAUCOMA LASER THERAPY 1
C GLAUCOMA VISUAL ACUITY REDUCED 1
C HYPERLIPIDAEMIA INTERSTITIAL LUNG DISEASE 1
C HYPERLIPIDAEMIA RENAL IMPAIRMENT 1
C HYPERTENSION INTERSTITIAL LUNG DISEASE 1
C HYPERTENSION RENAL IMPAIRMENT 1
C INSOMNIA INTERSTITIAL LUNG DISEASE 1
C INSOMNIA RENAL IMPAIRMENT 1
C MACULAR DEGENERATION CATARACT 2
C MACULAR DEGENERATION LASER THERAPY 2
C MACULAR DEGENERATION VISUAL ACUITY REDUCED 2
C OPEN ANGLE GLAUCOMA CATARACT 1
C OPEN ANGLE GLAUCOMA LASER THERAPY 1
C OPEN ANGLE GLAUCOMA VISUAL ACUITY REDUCED 1
C RENAL CELL CARCINOMA INTERSTITIAL LUNG DISEASE 2
C RENAL CELL CARCINOMA RENAL IMPAIRMENT 2
Ads by Google